{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:07:12Z","timestamp":1785427632733,"version":"3.56.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81302531"],"award-info":[{"award-number":["81302531"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Jiangsu Province of China","award":["BK20181492"],"award-info":[{"award-number":["BK20181492"]}]},{"name":"the Talents Planning of Six Summit Fields of Jiangsu Province","award":["2013-WSN-037"],"award-info":[{"award-number":["2013-WSN-037"]}]},{"name":"Postgraduate Research & Practice Innovation Program of Jiangsu Province","award":["KYCX17_1287"],"award-info":[{"award-number":["KYCX17_1287"]}]},{"name":"Postgraduate Research & Practice Innovation Program of Jiangsu Province","award":["SJCX18_0435"],"award-info":[{"award-number":["SJCX18_0435"]}]},{"name":"the National Key Clinical Department of Laboratory Medicine of China in Nanjing, Key laboratory for Laboratory Medicine of Jiangsu Province","award":["ZDXKB2016005"],"award-info":[{"award-number":["ZDXKB2016005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10875-022-01263-z","type":"journal-article","created":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T17:04:07Z","timestamp":1649264647000},"page":"1000-1008","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Development of Laboratory Parameters-Based Formulas in Predicting Short Outcomes for Adult Hemophagocytic Lymphohistiocytosis Patients with Different Underlying Diseases"],"prefix":"10.1007","volume":"42","author":[{"given":"Jun","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Qi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7170-9445","authenticated-orcid":false,"given":"Hua-Guo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,6]]},"reference":[{"issue":"2","key":"1263_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1182\/blood.2019000761","volume":"134","author":"S Albeituni","year":"2019","unstructured":"Albeituni S, Verbist KC, Tedrick PE, Tillman H, Picarsic J, Bassett R, et al. Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosis. Blood. 2019;134(2):147\u201359.","journal-title":"Blood"},{"issue":"19","key":"1263_CR2","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1182\/blood-2015-01-551622","volume":"125","author":"AM Schram","year":"2015","unstructured":"Schram AM, Berliner N. How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood. 2015;125(19):2908\u201314.","journal-title":"Blood"},{"issue":"5","key":"1263_CR3","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s10875-020-00801-x","volume":"40","author":"J Huang","year":"2020","unstructured":"Huang J, Yin G, Duan L, Tian T, Xu J, Wang J, et al. Prognostic value of blood-based inflammatory biomarkers in secondary hemophagocytic lymphohistiocytosis. J Clin Immunol. 2020;40(5):718\u201328.","journal-title":"J Clin Immunol"},{"issue":"1","key":"1263_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1532\/IJH97.07012","volume":"86","author":"E Ishii","year":"2007","unstructured":"Ishii E, Ohga S, Imashuku S, Yasukawa M, Tsuda H, Miura I, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol. 2007;86(1):58\u201365.","journal-title":"Int J Hematol"},{"issue":"6","key":"1263_CR5","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1016\/S2665-9913(20)30096-5","volume":"2","author":"P Mehta","year":"2020","unstructured":"Mehta P, Cron RQ, Hartwell J, Manson JJ, Tattersall RS. Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome. Lancet Rheumatol. 2020;2(6):e358\u201367.","journal-title":"Lancet Rheumatol."},{"issue":"9927","key":"1263_CR6","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","volume":"383","author":"M Ramos-Casals","year":"2014","unstructured":"Ramos-Casals M, Brito-Zeron P, Lopez-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. Lancet. 2014;383(9927):1503\u201316.","journal-title":"Lancet"},{"issue":"23","key":"1263_CR7","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1182\/blood.2018894618","volume":"133","author":"P La Rosee","year":"2019","unstructured":"La Rosee P, Horne A, Hines M, von Bahr GT, Machowicz R, Berliner N, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133(23):2465\u201377.","journal-title":"Blood"},{"issue":"1","key":"1263_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13023-020-1336-6","volume":"15","author":"J Zhou","year":"2020","unstructured":"Zhou J, Zhou J, Shen DT, Goyal H, Wu ZQ, Xu HG. Development and validation of the prognostic value of ferritin in adult patients with hemophagocytic lymphohistiocytosis. Orphanet J Rare Dis. 2020;15(1):71.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"1263_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s13023-021-01973-4","volume":"16","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Kong F, Wang S, Yu M, Xu Y, Kang J, et al. Increased levels of serum interleukin-10 are associated with poor outcome in adult hemophagocytic lymphohistiocytosis patients. Orphanet J Rare Dis. 2021;16(1):347.","journal-title":"Orphanet J Rare Dis"},{"key":"1263_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13023-015-0224-y","volume":"10","author":"F Li","year":"2015","unstructured":"Li F, Yang Y, Jin F, Dehoedt C, Rao J, Zhou Y, et al. Clinical characteristics and prognostic factors of adult hemophagocytic syndrome patients: a retrospective study of increasing awareness of a disease from a single-center in China. Orphanet J Rare Dis. 2015;10:20.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"1263_CR11","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.mayocp.2013.12.012","volume":"89","author":"SA Parikh","year":"2014","unstructured":"Parikh SA, Kapoor P, Letendre L, Kumar S, Wolanskyj AP. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin Proc. 2014;89(4):484\u201392.","journal-title":"Mayo Clin Proc"},{"key":"1263_CR12","doi-asserted-by":"publisher","first-page":"997","DOI":"10.2147\/CMAR.S183784","volume":"11","author":"YZ Liu","year":"2019","unstructured":"Liu YZ, Bi LQ, Chang GL, Guo Y, Sun S. Clinical characteristics of extranodal NK\/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis. Cancer Manag Res. 2019;11:997\u20131002.","journal-title":"Cancer Manag Res."},{"key":"1263_CR13","doi-asserted-by":"publisher","first-page":"749903","DOI":"10.3389\/fmed.2021.749903","volume":"8","author":"Y Li","year":"2021","unstructured":"Li Y, Guo C, Huang C, Jing L, Huang Y, Zhou R, et al. Development and evaluation of the prognostic nomogram to predict refractive error in patients with primary angle-closure glaucoma who underwent cataract surgery combined with goniosynechialysis. Front Med (Lausanne). 2021;8:749903.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"1263_CR14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124\u201331.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"1263_CR15","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1080\/16078454.2019.1660458","volume":"24","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Lu D, Ma S, Li L, Zhu J, Zhou, et al. Risk factors of early death in adult patients with secondary hemophagocytic lymphohistiocytosis a single-institution study of 171 Chinese patients. Hematology. 2019;24(1):606\u201312.","journal-title":"Hematology"},{"issue":"1","key":"1263_CR16","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s12879-021-06094-8","volume":"21","author":"M Meng","year":"2021","unstructured":"Meng M, Chen L, Zhang S, Dong X, Li W, Li R, et al. Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients. BMC Infect Dis. 2021;21(1):398.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"1263_CR17","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.1016\/j.clml.2020.10.009","volume":"21","author":"B Li","year":"2021","unstructured":"Li B, Guo J, Li T, Gu J, Zeng C, Xiao M, et al. Clinical characteristics of hemophagocytic lymphohistiocytosis associated with non-Hodgkin B-cell lymphoma: a multicenter retrospective study. Clin Lymphoma Myeloma Leuk. 2021;21(2):e198\u2013205.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"1263_CR18","doi-asserted-by":"crossref","unstructured":"Zoref-Lorenz A, Murakami J, Hofstetter L, Iyer SP, Alotaibi AS, Mohamed SF, et al 2021 An improved index for diagnosis and mortality prediction in malignancy associated hemophagocytic lymphohistiocytosis. Blood","DOI":"10.1182\/blood.2021012764"},{"issue":"9","key":"1263_CR19","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00277-016-2727-6","volume":"95","author":"Q Bin","year":"2016","unstructured":"Bin Q, Gao JH, Luo JM. Prognostic factors of early outcome in pediatric hemophagocytic lymphohistiocytosis: an analysis of 116 cases. Ann Hematol. 2016;95(9):1411\u20138.","journal-title":"Ann Hematol"},{"issue":"1","key":"1263_CR20","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s13023-020-01515-4","volume":"15","author":"X Li","year":"2020","unstructured":"Li X, Yan H, Zhang X, Huang J, Xiang ST, Yao Z, et al. Clinical profiles and risk factors of 7-day and 30-day mortality among 160 pediatric patients with hemophagocytic lymphohistiocytosis. Orphanet J Rare Dis. 2020;15(1):229.","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"1263_CR21","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/ijc.27412","volume":"131","author":"A Jiraskova","year":"2012","unstructured":"Jiraskova A, Novotny J, Novotny L, Vodicka P, Pardini B, Naccarati A, et al. Association of serum bilirubin and promoter variations in HMOX1 and UGT1A1 genes with sporadic colorectal cancer. Int J Cancer. 2012;131(7):1549\u201355.","journal-title":"Int J Cancer"},{"issue":"4","key":"1263_CR22","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/hep.1840400412","volume":"40","author":"SD Zucker","year":"2004","unstructured":"Zucker SD, Horn PS, Sherman KE. Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer. Hepatology. 2004;40(4):827\u201335.","journal-title":"Hepatology"},{"issue":"4","key":"1263_CR23","doi-asserted-by":"publisher","first-page":"715","DOI":"10.15171\/apb.2018.080","volume":"8","author":"E SaghebAsl","year":"2018","unstructured":"SaghebAsl E, Taheraghdam A, Rahmani F, Javadrashid R, Golzari SEJ, Ghaemian N, et al. Determination of the predictive value of serum bilirubin in patients with ischemic stroke: a prospective descriptive analytical study. Adv Pharm Bull. 2018;8(4):715\u20139.","journal-title":"Adv Pharm Bull."},{"issue":"5","key":"1263_CR24","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.semnephrol.2011.08.002","volume":"31","author":"RJ Johnson","year":"2011","unstructured":"Johnson RJ, Lanaspa MA, Gaucher EA. Uric acid: a danger signal from the RNA world that may have a role in the epidemic of obesity, metabolic syndrome, and cardiorenal disease: evolutionary considerations. Semin Nephrol. 2011;31(5):394\u20139.","journal-title":"Semin Nephrol"},{"issue":"11","key":"1263_CR25","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","volume":"78","author":"BN Ames","year":"1981","unstructured":"Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A. 1981;78(11):6858\u201362.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1263_CR26","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000122618","volume":"54","author":"WH Waugh","year":"2008","unstructured":"Waugh WH. Inhibition of iron-catalyzed oxidations by attainable uric acid and ascorbic acid levels: therapeutic implications for Alzheimer\u2019s disease and late cognitive impairment. Gerontology. 2008;54(4):238\u201343.","journal-title":"Gerontology"},{"issue":"3","key":"1263_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ejim.2011.11.013","volume":"23","author":"K Berend","year":"2012","unstructured":"Berend K, van Hulsteijn LH, Gans RO. Chloride: the queen of electrolytes? Eur J Intern Med. 2012;23(3):203\u201311.","journal-title":"Eur J Intern Med"},{"issue":"4","key":"1263_CR28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/088307388600100406","volume":"1","author":"FS Silverstein","year":"1986","unstructured":"Silverstein FS, Johnston MV. A model of methotrexate encephalopathy: neurotransmitter and pathologic abnormalities. J Child Neurol. 1986;1(4):351\u20137.","journal-title":"J Child Neurol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01263-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-022-01263-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01263-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:04:47Z","timestamp":1661385887000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-022-01263-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,6]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["1263"],"URL":"https:\/\/doi.org\/10.1007\/s10875-022-01263-z","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,6]]},"assertion":[{"value":"10 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study is in accordance with the Declaration of Helsinki and approved by the Ethics Committee of The First Affiliated Hospital of Nanjing Medical University (Nanjing, China) (2019-SR-066).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Patients signed informed consent regarding publishing their data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}